Claude Guerin

Prof. Claude Guerin

Medecine intensive réanimation, Hospital Édouard Herriot, Lyon, France
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2013 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
CGClaude Guerin
Claude Guerin
JRJean Reignier
Jean Reignier
JRJean-Christophe Richard
Jean-Christophe Richard
PBPascal Beuret
Pascal Beuret
AGArnaud Gacouin
Arnaud Gacouin
LALouis Ayzac
Louis Ayzac
Previous trials involving patients with the acute respiratory distress syndrome (ARDS) have failed to show a beneficial effect of prone positioning during mechanical ventilatory support on outcomes. We evaluated the effect of early application of prone positioning on outcomes in patients with severe ARDS.

13 June 2019 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
LPLaurent Papazian
Laurent Papazian
CACécile Aubron
Cécile Aubron
LBLaurent Brochard
Laurent Brochard
JCJean-Daniel Chiche
Jean-Daniel Chiche
ACAlain Combes
Alain Combes
HFHenri Faure
Henri Faure
Fifteen recommendations and a therapeutic algorithm regarding the management of acute respiratory distress syndrome (ARDS) at the early phase in adults are proposed. The Grade of Recommendation Assessment, Development and Evaluation (GRADE) methodology has been followed. Four recommendations (low tidal volume, plateau pressure limitation, no oscillatory ventilation, and prone position) had a high level of proof (GRADE 1 + or 1 −); four (high positive end-expiratory pressure [PEEP] in moderate and severe ARDS, muscle relaxants, recruitment maneuvers, and venovenous extracorporeal membrane oxygenation [ECMO]) a low level of proof (GRADE 2 + or 2 −); seven (surveillance, tidal volume for non ARDS mechanically ventilated patients, tidal volume limitation in the presence of low plateau pressure, PEEP > 5 cmH2O, high PEEP in the absence of deleterious effect, pressure mode allowing spontaneous ventilation after the acute phase, and nitric oxide) corresponded to a level of proof that did not allow use of the GRADE classification and were expert opinions. Lastly, for three aspects of ARDS management (driving pressure, early spontaneous ventilation, and extracorporeal carbon dioxide removal), the experts concluded that no sound recommendation was possible given current knowledge. The recommendations and the therapeutic algorithm were approved by the experts with strong agreement.

17 November 2004 in JAMA
Verified
Journal Article
Closed access
PDF file
CGClaude Guerin
Claude Guerin
SGSandrine Gaillard
Sandrine Gaillard
SLStephane Lemasson
Stephane Lemasson
LALouis Ayzac
Louis Ayzac
RGRaphaele Girard
Raphaele Girard
MKMichel Kaidomar
Michel Kaidomar
Research from JAMA — Effects of Systematic Prone Positioning in Hypoxemic Acute Respiratory Failure — A Randomized Controlled Trial — ContextA recent trial showed that placing patients with acute lung injury in the prone position did not increase survival; however, whether those results hold true for patients with hypoxemic acute respiratory failure (ARF) is unclear.ObjectiveTo determine whether prone positioning improves mortality in ARF patients.Design, Setting, and PatientsProspective, unblinded, multicenter controlled trial of 791 ARF patients in 21 general intensive care units in France using concealed randomization conducted from December 14, 1998, through December 31, 2002. To be included, patients had to be at least 18 years, hemodynamically stable, receiving mechanical ventilation, and intubated and had to have a partial pressure of arterial oxygen (PaO2) to fraction of inspired oxygen (FIO2) ratio of 300 or less and no contraindications to lying prone.InterventionsPatients were randomly assigned to prone position placement (n = 413), applied as early as possible for at least 8 hours per day on standard beds, or to supine position placement (n = 378).Main Outcome MeasuresThe primary end point was 28-day mortality; secondary end points were 90-day mortality, duration of mechanical ventilation, incidence of ventilator-associated pneumonia (VAP), and oxygenation.ResultsThe 2 groups were comparable at randomization. The 28-day mortality rate was 32.4% for the prone group and 31.5% for the supine group (relative risk [RR], 0.97; 95% confidence interval [CI], 0.79-1.19; P = .77). Ninety-day mortality for the prone group was 43.3% vs 42.2% for the supine group (RR, 0.98; 95% CI, 0.84-1.13; P = .74). The mean (SD) duration of mechanical ventilation was 13.7 (7.8) days for the prone group vs 14.1 (8.6) days for the supine group (P = .93) and the VAP incidence was 1.66 vs 2.14 episodes per 100-patients days of intubation, respectively (P = .045). The PaO2/FIO2 ratio was significantly higher in the prone group during the 28-day follow-up. However, pressure sores, selective intubation, and endotracheal tube obstruction incidences were higher in the prone group.ConclusionsThis trial demonstrated no beneficial outcomes and some safety concerns associated with prone positioning. For patients with hypoxemic ARF, prone position placement may lower the incidence of VAP.

10 November 2020 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
CGClaude Guerin
Claude Guerin
RARichard K. Albert
Richard K. Albert
JBJeremy Beitler
Jeremy Beitler
LGLuciano Gattinoni
Luciano Gattinoni
SJSamir Jaber
Samir Jaber
JMJordi Mancebo
Jordi Mancebo

1 October 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
EGEwan C. Goligher
Ewan C. Goligher
MDMartin Dres
Martin Dres
BPBhakti K. Patel
Bhakti K. Patel
SSSarina K. Sahetya
Sarina K. Sahetya
JBJeremy R. Beitler
Jeremy R. Beitler
FMFor the Pleural Pressure Working Group, Acute Respiratory Failure Section of the European Society of Intensive Care Medicine
For the Pleural Pressure Working Group, Acute Respiratory Failure Section of the European Society of Intensive Care Medicine
Mechanical ventilation can cause acute diaphragm atrophy and injury, and this is associated with poor clinical outcomes. Although the importance and impact of lung-protective ventilation is widely appreciated and well established, the concept of diaphragm-protective ventilation has recently emerged as a potential complementary therapeutic strategy. This Perspective, developed from discussions at a meeting of international experts convened by PLUG (the Pleural Pressure Working Group) of the European Society of Intensive Care Medicine, outlines a conceptual framework for an integrated lung- and diaphragm-protective approach to mechanical ventilation on the basis of growing evidence about mechanisms of injury. We propose targets for diaphragm protection based on respiratory effort and patient–ventilator synchrony. The potential for conflict between diaphragm protection and lung protection under certain conditions is discussed; we emphasize that when conflicts arise, lung protection must be prioritized over diaphragm protection. Monitoring respiratory effort is essential to concomitantly protect both the diaphragm and the lung during mechanical ventilation. To implement lung- and diaphragm-protective ventilation, new approaches to monitoring, to setting the ventilator, and to titrating sedation will be required. Adjunctive interventions, including extracorporeal life support techniques, phrenic nerve stimulation, and clinical decision-support systems, may also play an important role in selected patients in the future. Evaluating the clinical impact of this new paradigm will be challenging, owing to the complexity of the intervention. The concept of lung- and diaphragm-protective ventilation presents a new opportunity to potentially improve clinical outcomes for critically ill patients.

7 December 2017 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
CGClaude Guerin
Claude Guerin
SÑSilvio A. Ñamendys-Silva
Silvio A. Ñamendys-Silva
JCJ. M. Constantin
J. M. Constantin
GBG. Bellani
G. Bellani
PGP. Garcia-Olivares
P. Garcia-Olivares
TGthe ESICM Trials Group
the ESICM Trials Group